Treating depression with adjunctive antipsychotics

Efficacy of adjunctive brexpiprazole on the core symptoms of major depressive disorder: A post hoc analysis of two pooled clinical studies

(2018) J. Craig Nelson et al.   JOURNAL OF AFFECTIVE DISORDERS

Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment

(2017) Somaia Mohamed et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

(2016) Sidney H. Kennedy et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants

(2016) Suresh Durgam et al.   JOURNAL OF CLINICAL PSYCHIATRY

Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study

(2015) George I. Papakostas et al.   AMERICAN JOURNAL OF PSYCHIATRY

Adjunctive Ziprasidone in Major Depression and the Current Status of Adjunctive Atypical Antipsychotics

(2015) J. Craig Nelson   AMERICAN JOURNAL OF PSYCHIATRY

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

(2015) Gin S Malhi et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis

(2015) Xinyu Zhou et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants

(2015) Michael E. Thase et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder

(2015) Michael E. Thase et al.   JOURNAL OF CLINICAL PSYCHIATRY

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

(2015) Christoph U. Correll et al.   World Psychiatry

Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks?

(2015) T. Pringsheim et al.   BMJ-British Medical Journal

Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks?

(2015) T. Pringsheim et al.   BMJ-British Medical Journal

A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression

(2014) J. Craig Nelson et al.   JOURNAL OF AFFECTIVE DISORDERS

National Trends in Second-Generation Antipsychotic Augmentation for Nonpsychotic Depression

(2014) Tobias Gerhard et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder

(2014) Elizabeth Brunner et al.   NEUROPSYCHOPHARMACOLOGY

Aripiprazole augmentation to antidepressant therapy in Japanese patients with major depressive disorder: A randomized, double-blind, placebo-controlled study (ADMIRE study)

(2013) Kunitoshi Kamijima et al.   JOURNAL OF AFFECTIVE DISORDERS

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

(2013) Michael Bauer et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes

(2013) Glen I. Spielmans et al.   PLOS MEDICINE

The science and practice of lithium therapy

(2012) Gin S Malhi et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepressant Therapy (ADAPT-A Study)

(2012) Maurizio Fava et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Publication Bias in Antipsychotic Trials: An Analysis of Efficacy Comparing the Published Literature to the US Food and Drug Administration Database

(2012) Erick H. Turner et al.   PLOS MEDICINE

Therapeutic Options for Treatment-Resistant Depression

(2010) Richard C. Shelton et al.   CNS DRUGS

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study

(2010) Nizar El-Khalili et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder

(2010) Michael Bauer et al.   JOURNAL OF AFFECTIVE DISORDERS

Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials

(2009) J. Craig Nelson et al.   AMERICAN JOURNAL OF PSYCHIATRY

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder

(2009) Michael Bauer et al.   JOURNAL OF CLINICAL PSYCHIATRY